Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 41 out of 100. Risk factors

Topic: Risk, prevention and care in population studies

14,292 patients were diagnosed with dementia over 2018–2021 (age 76.5+/−10.3 years; 53.1% female), with 96.3% linked to a census-tract-level ADI. Only 6.4% of patients had an adequate evaluation (15.5% adequate labs, 21.9% adequate imaging) and 30.1% received a disease-specific diagnosis. Men had lower odds of receiving a disease-specific diagnosis (OR = 0.72; p<0.001), adjusted for all other factors. Patients were increasingly likely to receive disease-specific diagnoses from ages 50 – 90, with decreasing likelihood after age 90. Higher ADI (greater deprivation) increased the likelihood of undergoing adequate evaluation (tertile 2vs1 OR: 1.21, p=0.053; tertile 3vs1 OR: 1.29, p=0.036) but decreased the likelihood of receiving a disease-specific diagnosis (tertile 2vs1 OR: 0.89, p=0.043; tertile 3vs1 OR: 0.97, p=0.616). ADI had an opposite effect on evaluation and disease-specific diagnoses. Those in more disadvantaged neighborhoods were more likely to receive an adequate evaluation, but less likely to receive a disease-specific diagnosis. This finding may explain the lower rates of recruitment of historically marginalized populations into clinical trials. Disclosure: The institution of Dr. D’Abreu has received research support from Alzheimer’s and Related Diseases Research Award Fund (Virginia Center on Aging in the College of Health Professions). The institution of Dr. Chernyavskiy has received research support from Institute of Education Sciences. The institution of an immediate family member of Dr. Chernyavskiy has received research support from Institute of Education Sciences. The institution of Dr. Chernyavskiy has received research support from Commonwealth of Virginia ARDRAF.

Key findings

Why it matters

In this group of dementia patients, only 6.4% received an adequate evaluation and 30.1% received a disease-specific diagnosis. People in more disadvantaged neighborhoods were more likely to get an adequate evaluation but less likely to receive a disease-specific diagnosis.

Study details

How this study scored 41/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 4 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 3 of 5; Sample size 3 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. Total 41 of 100.41 of 100 points earned59 not earned

Published in a leading specialty journal. Scored zero for study design and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (Neurology)
Journal's citation record 4 / 4 Neurology: journal h-index 525 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 3 / 5 2023 — within 6 year(s) of the newest study here
Sample size 3 / 4 4,600 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.2 citations a year over 5 year(s) since 2023
Impact for its field and year 1 / 6 Cited 0.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Pavel Chernyavskiy: h-index 20 (OpenAlex, whole career)
Institution's track record 1 / 3 University of Virginia: institution h-index 1,118 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Total 41 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

D’Abreu, A., & Chernyavskiy, P. (2023). Does the Area Deprivation Index (ADI) influence dementia evaluation and diagnosis in Virginia? (S29.004). Neurology. https://doi.org/10.1212/wnl.0000000000202532

Vancouver

D’Abreu A, Chernyavskiy P. Does the Area Deprivation Index (ADI) influence dementia evaluation and diagnosis in Virginia? (S29.004). Neurology. 2023. doi:10.1212/wnl.0000000000202532.

BibTeX

@article{dabreu2023-8f88e7a1,
  author  = {D’Abreu, Anelyssa and Chernyavskiy, Pavel},
  title   = {{Does the Area Deprivation Index (ADI) influence dementia evaluation and diagnosis in Virginia? (S29.004)}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000202532},
  url     = {https://doi.org/10.1212/wnl.0000000000202532}
}

Related studies in Risk factors

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Similar studies

More on Risk factors

See all studies in Risk factors →